Takeda’s Take On Patent Certification Rules In Colchicine Dispute Rejected
This article was originally published in The Pink Sheet Daily
Executive Summary
A federal judge tosses Takeda’s suit against FDA, finding Hikma did not need to reference Takeda’s Colcrys or certify Colcrys patents to obtain approval of its colchicine product.